Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 1680
  • Home
  • Print this page
  • Email this page
ORIGINAL ARTICLE
Year : 2022  |  Volume : 19  |  Issue : 1  |  Page : 84

In vivo comparison of bioceramic putty and mineral trioxide aggregate as pulpotomy medicament in primary molars. A 12-month follow-up randomized clinical trial


1 Department of Pediatric and Preventive Dentistry, Meghna Dental College, Nizamabad, Telangana, India
2 Department of Pediatric and Preventive Dentistry, GSL Dental College and Hospital, Rajahmahendravaram, Andhra Pradesh, India
3 Department of Pediatric and Preventive Dentistry, Vishnu Dental College, Bhimavaram, Andhra Pradesh, India
4 Department of Pediatric and Preventive Dentistry, Vishnu Dental College and Hospital, Bhimavaram, Andhra Pradesh, India

Correspondence Address:
Dr. Charan Teja Vemagiri
D. No: 2-49, Near ZP Elementary School, Diwancheruvu, East Godavari District, Rajahmahendravaram - 533 296, Andhra Pradesh
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1735-3327.359322

Rights and Permissions

Background: Pulpotomy is one of the common vital pulp therapy procedures for primary molars. The present trend in pulpotomy materials is to use regenerative materials that promote dentinogenesis. Mineral trioxide aggregate (MTA) is a very popular pulpotomy material. However, it has some limitations including difficult handling characteristics and long setting time. Tricalcium silicate cements evolved, in which bioceramic cements came into existence, have better properties than MTA. The aims and objectives of the study are to evaluate the efficacy of bioceramic putty with MTA as a pulp medicament in primary molars. Materials and Methods: In this randomized in vivo study, sixty primary molars in children aged 4–9 years indicated for pulpotomy were selected. They were assigned using nonprobability convenient sampling technique into two groups: test group – bioceramic putty (EndoSequence Root Repair Material) and control group – MTA (Angelus). After pulp therapy, teeth were restored with stainless steel crowns. Recall clinical and radiographic evaluation was done at 3-, 6-, and 12-month interval to assess success rate. The data were statistically analyzed using Chi-square test, and P ≤ 0.05 was set for statistical significance. Results: At 3-month interval, the success rates were 96.7% and 93.1% with bioceramic and MTA groups, respectively. At 6- and 12-month interval, the success rates were 93.3% and 93.1% with bioceramic and MTA groups, respectively. However, the difference in success rate between the groups was statistically not significant at all the time intervals (P = 0.533 at 3 months, P = 0.972 at 6 and 12 months). Conclusion: Bioceramic putty exhibited comparable results to MTA. Hence, it can be considered alternative pulpotomy agent.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed274    
    Printed10    
    Emailed0    
    PDF Downloaded42    
    Comments [Add]    

Recommend this journal